Akzo Nobel N V S/Adr
(AKZOY)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2019 | 12-2018 | 12-2017 | 12-2016 | 12-2015 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 1,423,520 | 3,305,619 | 1,494,257 | 1,636,661 | 1,515,751 |
| Marketable Securities | 154,560 | 6,448,260 | N/A | N/A | N/A |
| Receivables | 2,388,960 | 2,528,521 | 2,219,909 | 3,084,094 | 3,043,716 |
| Inventories | 1,275,680 | 1,345,159 | 1,236,548 | 1,695,311 | 1,670,102 |
| Other current assets | 70,560 | 87,391 | 5,270,586 | 65,290 | 76,620 |
| TOTAL | $5,313,280 | $13,714,950 | $10,221,300 | $6,481,356 | $6,306,189 |
| Non-Current Assets | |||||
| PPE Net | 1,904,000 | 2,064,388 | 2,070,710 | 4,636,654 | 4,445,091 |
| Investments And Advances | 168,000 | 161,797 | 133,375 | 178,163 | 183,223 |
| Intangibles | 4,060,000 | 4,083,898 | 3,853,193 | 4,883,426 | 4,614,989 |
| Other Non-Current Assets | 3,096,800 | 2,158,868 | 2,007,412 | 1,742,897 | 2,176,467 |
| TOTAL | $9,228,800 | $8,468,951 | $8,064,690 | $11,441,140 | $11,419,770 |
| Total Assets | $14,542,080 | $22,183,900 | $18,285,990 | $17,922,490 | $17,725,950 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 2,694,720 | 3,123,745 | 3,158,058 | 3,845,435 | 3,856,558 |
| Other current liabilities | 258,720 | 249,191 | 2,754,541 | 466,985 | 500,808 |
| TOTAL | $3,362,240 | $4,346,080 | $7,145,757 | $4,662,106 | $5,104,693 |
| Non-Current Liabilities | |||||
| Long Term Debt | 2,287,040 | 2,124,619 | 2,599,690 | 2,925,850 | 2,399,661 |
| Other Non-Current Liabilities | 1,056,160 | 996,764 | 1,008,228 | 2,053,850 | 1,974,362 |
| TOTAL | $3,823,680 | $3,620,946 | $4,011,435 | $5,476,563 | $4,870,390 |
| Total Liabilities | $7,185,920 | $7,967,026 | $11,157,190 | $10,138,670 | $9,975,083 |
| Shareholders' Equity | |||||
| Common Shares | 112,000 | 604,672 | 570,802 | 557,726 | 552,999 |
| Other shareholders' equity | 7,244,160 | 12,480,810 | 5,688,800 | 6,400,574 | 6,533,829 |
| TOTAL | $7,356,160 | $14,216,880 | $7,128,802 | $7,783,824 | $7,750,871 |
| Total Liabilities And Equity | $14,542,080 | $22,183,906 | $18,285,992 | $17,922,494 | $17,725,954 |